Nosocomial pneumonia. A continuing major problem.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000453:epidemiology*; D003428:Cross Infection / Q000453:epidemiology*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology; D004927:Escherichia coli Infections / Q000453:epidemiology; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000453:epidemiology; D008396:Maryland; D011008:Pneumococcal Infections / Q000453:epidemiology; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D011552:Pseudomonas Infections / Q000453:epidemiology; D011550:Pseudomonas aeruginosa
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin